QT Imaging Holdings, Inc. (QTI): Cost of Revenue
$10.34M
Year ended 2025-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.34M | +361.9% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $2.24M | n/m | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $135.0K | n/a | 2025-03-31, From 2023-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $10.34M | +361.9% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $6.81M | -2.7% |
| CapsoVision, Inc (CV) | 2025-12-31 | $6.38M | +18.6% |
| Escalon Medical Corp (ESMC) | 2026-06-30 | $7.17M | +9.7% |
| Precision Optics Corporation, Inc. (POCI) | 2026-06-30 | $26.10M | +66.4% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $4.24M | +12.1% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $15.31M | +24.2% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $3.15M | +2.7% |
| Iridex Corp (IRIX) | 2026-01-03 | $33.45M | +14.7% |
Compare QTI, HYPR, CV, ESMC side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗